Use of Noninvasive Biomarker Tests vs. FibroScan for Predicting Significant Fibrosis in Egyptian Pediatric Cancer Survivors with Chronic Hepatitis C Virus Infection
Dalia N Toaima, Fatma A Marzouk, Alaa El-Haddad, Aisha Elsharkawy, Gamal E Esmat, Manal H El-Sayed · 2026
Read Use of Noninvasive Biomarker Tests vs. FibroScan for Predicting Significant Fibrosis in Egyptian Pediatric Cancer Survivors with Chronic Hepatitis C Virus Infection by Dalia N Toaima, Fatma A Marzouk, Alaa El-Haddad, Aisha Elsharkawy, Gamal E Esmat, Manal H El-Sayed (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13591162.txt.
Description
Dalia Toaima and co-authors compare cheap blood scores against a scanner for grading liver scarring in young cancer survivors with hepatitis C, in a 2026 study. Egyptian children on chemotherapy face raised infection risk from transfusions and weak immunity. Fifty-one survivors with lasting infection, median age 13.5, joined the study at two Cairo centers.
Each child got a stiffness scan of the liver plus two blood-based scores, APRI and FIB-4. About one in five showed advanced scarring. Blood scores rose with stiffness, and APRI called advanced scarring more truly than FIB-4, with cut points of 0.86 and 0.52. The authors back both scores as stand-ins where scanners are scarce, with APRI first choice.
Catalog record
| CREATOR | Dalia N Toaima, Fatma A Marzouk, Alaa El-Haddad, Aisha Elsharkawy, Gamal E Esmat, Manal H El-Sayed |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |